Brief: Glenmark Pharma To Launch Sodium Phosphates Injection In USA
27/02/2026 08:08
Feb 27 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS: TO LAUNCH SODIUM PHOSPHATES INJECTION IN USA SODIUM PHOSPHATES INJECTION DISTRIBUTION TO BEGIN IN APRIL 2026 Source text: ID:nNSE1w4VMD Further company coverage: GLEN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter